These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 350630)

  • 21. Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells.
    Matsumura M; Akiyoshi H; Saito S; Mori H
    Endocrinol Jpn; 1979 Apr; 26(2):233-7. PubMed ID: 477614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vagus, gastric inhibitory polypeptide, and HCl on gastrin and somatostatin release from perfused pig antrum.
    Holst JJ; Jensen SL; Knuhtsen S; Nielsen OV; Rehfeld JF
    Am J Physiol; 1983 May; 244(5):G515-22. PubMed ID: 6133453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric inhibitory polypeptide and insulin secretion after infusion of acetylcholine, catecholamines, and gut hormones.
    Williams RH; Biesbroeck J
    Proc Soc Exp Biol Med; 1980 Jan; 163(1):39-47. PubMed ID: 7352145
    [No Abstract]   [Full Text] [Related]  

  • 24. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
    Lonovics J; Devitt P; Rayford PL; Thompson JC
    Surg Forum; 1979; 30():407-9. PubMed ID: 538649
    [No Abstract]   [Full Text] [Related]  

  • 25. Gastrointestinal hormones and the control of insulin secretion.
    Brown JC; Otte SC
    Diabetes; 1978 Jul; 27(7):782-7. PubMed ID: 350679
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of met-enkephalin and naloxone on somatostatin and insulin secretion from the isolated, perfused rat pancreas.
    Di Scala-Guénot D; McIntosh CH
    Diabetes; 1985 Dec; 34(12):1283-7. PubMed ID: 2866128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of glucagon, Neurotensin, and vasoactive intestinal polypeptide on somatostatin release from perifused rat hypothalamus.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jun; 110(6):2113-7. PubMed ID: 6122561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide stimulates hormone release from corticotropic cells in culture.
    Westendorf JM; Phillips MA; Schonbrunn A
    Endocrinology; 1983 Feb; 112(2):550-7. PubMed ID: 6129133
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormone release from pancreatic islets perfused from venous side.
    Kawai K; Chiba Y; Okuda Y; Yamashita K
    Diabetes; 1987 Mar; 36(3):256-60. PubMed ID: 2879756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro.
    Tapia-Arancibia L; Arancibia S; Bluet-Pajot MT; Enjalbert A; Epelbaum J; Priam M; Kordon C
    Eur J Pharmacol; 1980 May; 63(2-3):235-6. PubMed ID: 6103817
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Gastric inhibitory polypeptide (GIP): a potent stimulator of insulin release.
    Tze WJ
    Gastroenterology; 1975 Mar; 68(3):621-2. PubMed ID: 1089578
    [No Abstract]   [Full Text] [Related]  

  • 32. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of furosemide and indapamide upon pancreatic insulin and somatostatin secretion in vitro.
    Hermansen K; Schmitz O; Arnfred J; Mogensen CE
    Diabetes Res; 1986 May; 3(4):221-3. PubMed ID: 2874909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of calcium on the secretion of somatostatin and insulin from pancreatic islets.
    Kanatsuka A; Makino H; Matsushima Y; Kasanuki J; Osegawa M; Kumagai A
    Endocrinology; 1981 Jun; 108(6):2254-7. PubMed ID: 6112135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of gut hormone on insulin and glucagon secretion].
    Ohneda A; Ketterer H; Eisentraut AM; Unger RH
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():191-203. PubMed ID: 4907220
    [No Abstract]   [Full Text] [Related]  

  • 37. [Endocrinology and molecular physiopathology].
    Rev Med Brux; 1984 Mar; 5(3):137-58. PubMed ID: 6144155
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets.
    Hellman B; Salehi A; Gylfe E; Dansk H; Grapengiesser E
    Endocrinology; 2009 Dec; 150(12):5334-40. PubMed ID: 19819962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of gut peptides on glucose-stimulated insulin release by monolayer cultures of neonatal rat islet cells.
    Fujimoto WY
    Horm Metab Res; 1981 Mar; 13(3):135-8. PubMed ID: 7016701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E1: stimulation of somatostatin and insulin responses to glucose from the isolated perfused rat pancreas.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Ishida H; Imura H
    Prostaglandins Leukot Med; 1982 Jun; 8(6):593-7. PubMed ID: 6125951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.